The Hefei National High-tech Industry Development Zone has experienced a significant wave of expansion by its homegrown companies in 2025, adding projects worth several billion yuan spanning biomedicine, smart equipment, and digital energy.

One major project is Anhui Anke Biotechnology's new complex. The biotech pioneer is one of the earliest GEM-listed firm in China. It is building an integrated R&D and production center with an investment of 2 billion yuan (US$288.26 million) in the high-tech zone.

Another project is CSG's digital energy production base worth 1.5 billion yuan. The company, built in 2014, has steadily become an industry leader. Its new production base aims to form a cluster of the digital energy enterprises.

Other projects include Anhui Wanyi Science and Technology's 400-million-yuan high-end mass spectrometer project.

These companies' decisions stem from the zone's well-developed industrial ecosystem and efficient government services. The zone's Enterprise Home platform resolved 93.2% of 824 corporate requests in 2025, with 99.4% satisfaction rate. A big data model also accelerates project launches by matching land with needs.

The expansions are creating a chain reaction, attracting upstream and downstream businesses and forming a cycle of "growth-investment-upgrading." Currently, the zone has established a mature supporting system across industrial chains, a convenient R&D collaboration network, and a stable talent supply, providing a solid foundation for sustained development.

As a core innovation hub for industrial development, the Hefei National High-tech Industry Development Zone is enhancing its ecosystem to help firms transition from one-time investments to long-term growth. The upcoming launch of key projects will further strengthen its industrial structure and global competitiveness.